Literature DB >> 23210928

Managing coronary thrombus in the cath lab during PCI.

John A Ambrose.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23210928      PMCID: PMC3465824          DOI: 10.2174/157340312803217166

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


× No keyword cloud information.
The last two articles specifically address the question of therapeutic maneuvers for dealing with intracoronary thrombus during PCI. Either the thrombus is removed by aspiration or manual thrombectomy or embolic protection devices are deployed to prevent downstream embolization. Are there any other methods in selected cases? No one in the symposium has considered thrombolytic therapy as a method for dissolving thrombus during PCI. In 1994, our group published the Thrombolyisis and Angioplasty in UnStable Angina (TAUSA) trial which found that routine intra coronary thrombolytic therapy immediately before and after balloon angioplasty for unstable angina was detrimental [1]. However, that was prior to stenting. Other studies indicated that in selected cases, an infusion of IC thrombolytics could be effective for dissolving large intracoronary thrombi albeit at the risk of increasing bleeding complications [2, 3]. In the following case done in 2012, a patient with an ectatic, tortuous right coronary artery with an intra coronary thrombus distal to a severe complex lesion underwent intervention after a NSTEMI. The wire could not cross the lesion, so mechanical and aspiration thrombectomy were not an option. The patient was treated with IV integrilin overnight and 15milligrams of tissue plasminogen activator (t-PA) were infused into the ostium of the right coronary artery over 20 minutes. The sheath was left in place and the patient returned the next day. At that time, a Kinetics-Plus wire was successfully placed across the lesion and a 5.0mm bare metal stenting was deployed with excellent results. The t-PA/integrilin combination had dissolved the thrombus distal to the lesion (Fig. ). The patient tolerated the procedure without significant bleeding. These results underscore the possibility in very selected cases of utilizing this combination approach for large intra coronary thrombi in an open artery when other approaches are not possible. Whether integrilin alone with an anti thrombin would have produced the same results is unknown but this thrombus was likely fibrin rich and these are quite sensitive to small doses (10 to 15mgs) of a locally delivered thrombolytic.
  3 in total

1.  Rapid thrombus dissolution by continuous infusion of urokinase through an intracoronary perfusion wire prior to and following PTCA: results in native coronaries and patent saphenous vein grafts.

Authors:  A T Chapekis; B S George; R J Candela
Journal:  Cathet Cardiovasc Diagn       Date:  1991-06

2.  Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up.

Authors:  J R Hartmann; L S McKeever; N J Stamato; V J Bufalino; J C Marek; A S Brown; M J Goodwin; J M Cahill; E L Enger
Journal:  J Am Coll Cardiol       Date:  1991-11-15       Impact factor: 24.094

3.  Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial.

Authors:  J A Ambrose; O D Almeida; S K Sharma; S R Torre; J D Marmur; D H Israel; D E Ratner; M B Weiss; C E Hjemdahl-Monsen; R K Myler
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.